(Circulation. 1999;99:3071-3078.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
From Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pa (G.C., R.R.); the Department of Experimental Medicine and Pathology, University "La Sapienza," Rome, Italy (G.C.); the Department of Cardiology, I.R.C.C.S., INM "Neuromed," Pozzilli (IS) (G.C., C.M., A.N., G. Sgaramella, A.d.R., B.T., G.L.); the Department of Internal Medicine, "Federico II" University, Naples, Italy (B.T., G.L.); Children's Hospital of Pittsburgh, Rangos Research Center, University of Pittsburgh School of Medicine, Pittsburgh, Pa (G. Stassi); and the Department of Surgical, Anatomical, and Oncological Sciences, Anatomy Section, University of Palermo, Italy (G. Stassi, F.F.).
Correspondence to Gianluigi Condorelli, MD, PhD, Kimmel Cancer Center (Room 1006), 233 S 10th St, Philadelphia PA, 19107. E-mail condore1{at}jeflin.tju.edu
BackgroundLeft ventricular hypertrophy (LVH) represents both an adaptive response to increased cardiac work load and a precursor state of heart failure. Recent evidence linked cardiac myocyte death by apoptosis with LVH and heart failure. It remained unclear, however, whether apoptosis participated in the transition from LVH to left ventricular dysfunction (LVD).
Methods and ResultsCardiac myocyte apoptotic events and changes in apoptosis-specific genes were studied in a rat model of chronic pressure overload induced by transverse aortic constriction. The changes in left ventricular geometry and function were assessed by echocardiography. Transverse aortic constriction rats progressively developed "concentric" LVH and subsequently, LVD. A similar distribution of LVH and LVD was found 18 weeks after surgery. At this time point, we determined the occurrence of myocyte apoptosis by DNA laddering, in situ DNA TUNEL labeling, and light and electron microscopy. The monitoring of proapoptotic and antiapoptotic genes was determined by Western blot and immunohistochemistry. Our data demonstrated that cardiomyocyte apoptotic events increased from virtually undetectable (in sham-operated controls, SH) to 0.8/103 and 1.5/103 positive nuclei in LVH and LVD, respectively. Fibrosis also increased in the subendocardial and midwall regions of LVH and LVD rats compared with SH. Expression of the proapoptotic gene bax increased, whereas that of antiapoptotic gene bcl-2 decreased in LVH and LVD compared with SH.
ConclusionsThese data suggest that in response to chronic pressure overload, cardiomyocyte-specific apoptosis contributed to the transition from LVH to LVD. LVH and LVD were accompanied by a dramatic cardiomyocyte upregulation of the proapoptotic gene bax and reduced bcl-2/bax ratio, predisposing cardiomyocytes to apoptosis.
Key Words: cells heart failure genes apoptosis hypertrophy
This article has been cited by other articles:
![]() |
S. C. Kolwicz, S. M. MacDonnell, B. F. Renna, P. O. Reger, R. Seqqat, K. Rafiq, Z. V. Kendrick, S. R. Houser, A. Sabri, and J. R. Libonati Left ventricular remodeling with exercise in hypertension Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1361 - H1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Park, Y.-T. Shen, V. Gaussin, G. R. Heyndrickx, J. Bartunek, R. R. G. Resuello, F. F. Natividad, R. N. Kitsis, D. E. Vatner, and S. F. Vatner Apoptosis predominates in nonmyocytes in heart failure Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H785 - H791. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Choi, D. B. Cowan, A. M. Moran, S. D. Colan, C. Stamm, K. Takeuchi, I. Friehs, P. J. del Nido, and F. X. McGowan Jr. Myocyte apoptosis occurs early during the development of pressure-overload hypertrophy in infant myocardium. J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1356 - 1362.e3. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Dorn II Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling Cardiovasc Res, February 15, 2009; 81(3): 465 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bogazzi, D. Russo, F. Raggi, F. Ultimieri, C. Urbani, M. Gasperi, L. Bartalena, and E. Martino Transgenic Mice Overexpressing Growth Hormone (GH) Have Reduced or Increased Cardiac Apoptosis through Activation of Multiple GH-Dependent or -Independent Cell Death Pathways Endocrinology, November 1, 2008; 149(11): 5758 - 5769. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Mani, H. Shiraishi, S. Balasubramanian, K. Yamane, M. Chellaiah, G. Cooper, N. Banik, M. R. Zile, and D. Kuppuswamy In vivo administration of calpeptin attenuates calpain activation and cardiomyocyte loss in pressure-overloaded feline myocardium Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H314 - H326. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Van Linthout, F. Spillmann, A. Riad, C. Trimpert, J. Lievens, M. Meloni, F. Escher, E. Filenberg, O. Demir, J. Li, et al. Human Apolipoprotein A-I Gene Transfer Reduces the Development of Experimental Diabetic Cardiomyopathy Circulation, March 25, 2008; 117(12): 1563 - 1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Gustafsson and R. A. Gottlieb Heart mitochondria: gates of life and death Cardiovasc Res, January 15, 2008; 77(2): 334 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Morisco, C. Marrone, V. Trimarco, S. Crispo, M. G. Monti, J. Sadoshima, and B. Trimarco Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression Cardiovasc Res, December 1, 2007; 76(3): 453 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Sharma, S. Dhingra, N. Khaper, and P. K. Singal Activation of apoptotic processes during transition from hypertrophy to heart failure in guinea pigs Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1384 - H1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Yang, B. Y. Choi, Y.-H. Lee, Y.-G. Kim, M.-C. Cho, S.-E. Hong, D. H. Kim, R. J. Hajjar, and W. J. Park Gene profiling during regression of pressure overload-induced cardiac hypertrophy Physiol Genomics, June 19, 2007; 30(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hang, Z. Huang, S. Jiang, J. Gong, C. Wang, D. Xie, and H. Ren Apoptosis in pressure overload-induced cardiac hypertrophy is mediated, in part, by adenine nucleotide translocator-1. Ann. Clin. Lab. Sci., December 1, 2006; 36(1): 88 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lemmens, V. F. M. Segers, M. Demolder, and G. W. De Keulenaer Role of Neuregulin-1/ErbB2 Signaling in Endothelium-Cardiomyocyte Cross-talk J. Biol. Chem., July 14, 2006; 281(28): 19469 - 19477. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Galvez, E. W. Brunskill, Y. Marreez, B. J. Benner, K. M. Regula, L. A. Kirschenbaum, and G. W. Dorn II Distinct Pathways Regulate Proapoptotic Nix and BNip3 in Cardiac Stress J. Biol. Chem., January 20, 2006; 281(3): 1442 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. De Acetis, A. Notte, F. Accornero, G. Selvetella, M. Brancaccio, C. Vecchione, M. Sbroggio, F. Collino, B. Pacchioni, G. Lanfranchi, et al. Cardiac Overexpression of Melusin Protects From Dilated Cardiomyopathy Due to Long-Standing Pressure Overload Circ. Res., May 27, 2005; 96(10): 1087 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. J. Buermans, E. M. Redout, A. E. Schiel, R. J. P. Musters, M. Zuidwijk, P. P. Eijk, C. van Hardeveld, S. Kasanmoentalib, F. C. Visser, B. Ylstra, et al. Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure Physiol Genomics, May 11, 2005; 21(3): 314 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Pillai, H. M. Russell, J. Raman, V. Jeevanandam, and M. P. Gupta Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H486 - H496. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Kuster, E. Kotlyar, M. K. Rude, D. A. Siwik, R. Liao, W. S. Colucci, and F. Sam Mineralocorticoid Receptor Inhibition Ameliorates the Transition to Myocardial Failure and Decreases Oxidative Stress and Inflammation in Mice With Chronic Pressure Overload Circulation, February 1, 2005; 111(4): 420 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sarkar, M. Chawla-Sarkar, D. Young, K. Nishiyama, M. E. Rayborn, J. G. Hollyfield, and S. Sen Myocardial Cell Death and Regeneration during Progression of Cardiac Hypertrophy to Heart Failure J. Biol. Chem., December 10, 2004; 279(50): 52630 - 52642. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Philipp, I. Pagel, K. Hohnel, J. Lutz, J. Buttgereit, T. Langenickel, P. Hamet, R. Dietz, and R. Willenbrock Regulation of caspase 3 and Fas in pressure overload-induced left ventricular dysfunction Eur J Heart Fail, December 1, 2004; 6(7): 845 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Crow, K. Mani, Y.-J. Nam, and R. N. Kitsis The Mitochondrial Death Pathway and Cardiac Myocyte Apoptosis Circ. Res., November 12, 2004; 95(10): 957 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Pitts and C. F. Toombs Coverslip hypoxia: a novel method for studying cardiac myocyte hypoxia and ischemia in vitro Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1801 - H1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhao, A. Chow, J. Powers, G. Fajardo, and D. Bernstein Microarray analysis of gene expression after transverse aortic constriction in mice Physiol Genomics, September 16, 2004; 19(1): 93 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Khoynezhad, Z. Jalali, and A. J. Tortolani Apoptosis: Pathophysiology and therapeutic implications for the cardiac surgeon Ann. Thorac. Surg., September 1, 2004; 78(3): 1109 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Kang, P. Yue, Z. Liu, O. Tarnavski, N. Bodyak, and S. Izumo Alterations in apoptosis regulatory factors during hypertrophy and heart failure Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H72 - H80. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Gustafsson, J. G. Tsai, S. E. Logue, M. T. Crow, and R. A. Gottlieb Apoptosis Repressor with Caspase Recruitment Domain Protects against Cell Death by Interfering with Bax Activation J. Biol. Chem., May 14, 2004; 279(20): 21233 - 21238. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Thatte, J.-H. Rhee, S. E. Zagarins, P. R. Treanor, V. Birjiniuk, M. D. Crittenden, and S. F. Khuri Acidosis-induced apoptosis in human and porcine heart Ann. Thorac. Surg., April 1, 2004; 77(4): 1376 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hayakawa, M. Chandra, W. Miao, J. Shirani, J. H. Brown, G. W. Dorn II, R. C. Armstrong, and R. N. Kitsis Inhibition of Cardiac Myocyte Apoptosis Improves Cardiac Function and Abolishes Mortality in the Peripartum Cardiomyopathy of G{alpha}q Transgenic Mice Circulation, December 16, 2003; 108(24): 3036 - 3041. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Moorjani, P. Catarino, R. El-Sayed, S. Al-Ahmed, B. Meyer, F. Al-Mohanna, and S. Westaby A pressure overload model to track the molecular biology of heart failure Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 920 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Qin, J. Shite, and C.-s. Liang Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H822 - H832. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Cappola, L. Cope, A. Cernetich, L. A. Barouch, K. Minhas, R. A. Irizarry, G. Parmigiani, S. Durrani, T. Lavoie, E. P. Hoffman, et al. Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophy Physiol Genomics, June 24, 2003; 14(1): 25 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Lips, L. J. deWindt, D. J.W. van Kraaij, and P. A. Doevendans Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy Eur. Heart J., May 2, 2003; 24(10): 883 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Fortuno, A. Gonzalez, S. Ravassa, B. Lopez, and J. Diez Clinical implications of apoptosis in hypertensive heart disease Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1495 - H1506. [Full Text] [PDF] |
||||
![]() |
C. Morisco, J. Sadoshima, B. Trimarco, R. Arora, D. E. Vatner, and S. F. Vatner Is treating cardiac hypertrophy salutary or detrimental: the two faces of Janus Am J Physiol Heart Circ Physiol, April 1, 2003; 284 (4): H1043 - H1047. [Full Text] [PDF] |
||||
![]() |
A. Abbate, G. G. L. Biondi-Zoccai, R. Bussani, A. Dobrina, D. Camilot, F. Feroce, R. Rossiello, F. Baldi, F. Silvestri, L. M. Biasucci, et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure J. Am. Coll. Cardiol., March 5, 2003; 41(5): 753 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Condorelli, A. Drusco, G. Stassi, A. Bellacosa, R. Roncarati, G. Iaccarino, M. A. Russo, Y. Gu, N. Dalton, C. Chung, et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice PNAS, September 17, 2002; 99(19): 12333 - 12338. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yaniv, M. Shilkrut, R. Lotan, G. Berke, S. Larisch, and O. Binah Hypoxia predisposes neonatal rat ventricular myocytes to apoptosis induced by activation of the Fas (CD95/Apo-1) receptor: Fas activation and apoptosis in hypoxic myocytes Cardiovasc Res, June 1, 2002; 54(3): 611 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jankala, C. J. P. Eriksson, K. K. Eklund, M. Harkonen, and T. Maki COMBINED CALCIUM CARBIMIDE AND ETHANOL TREATMENT INDUCES HIGH BLOOD ACETALDEHYDE LEVELS, MYOCARDIAL APOPTOSIS AND ALTERED EXPRESSION OF APOPTOSIS-REGULATING GENES IN RAT Alcohol Alcohol., May 1, 2002; 37(3): 222 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. GILL, R. MESTRIL, and A. SAMALI Losing heart: the role of apoptosis in heart disease--a novel therapeutic target? FASEB J, February 1, 2002; 16(2): 135 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. CONDORELLI, J. K. AYCOCK, G. FRATI, and C. NAPOLI Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice FASEB J, October 1, 2001; 15(12): 2162 - 2170. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sugino, R. Ozono, S. Kurisu, H. Matsuura, M. Ishida, T. Oshima, M. Kambe, Y. Teranishi, H. Masaki, and H. Matsubara Apoptosis Is Not Increased in Myocardium Overexpressing Type 2 Angiotensin II Receptor in Transgenic Mice Hypertension, June 1, 2001; 37(6): 1394 - 1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Adachi, H. Ito, M. Tamamori-Adachi, Y. Ono, T. Nozato, S. Abe, M.-a. Ikeda, F. Marumo, and M. Hiroe Cyclin A/cdk2 Activation Is Involved in Hypoxia-Induced Apoptosis in Cardiomyocytes Circ. Res., March 2, 2001; 88(4): 408 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gupta, A. J.C Prahash, and I. S Anand Myocyte contractile function is intact in the post-infarct remodeled rat heart despite molecular alterations Cardiovasc Res, October 1, 2000; 48(1): 77 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Kang and S. Izumo Apoptosis and Heart Failure : A Critical Review of the Literature Circ. Res., June 9, 2000; 86(11): 1107 - 1113. [Full Text] [PDF] |
||||
![]() |
M. CATTARUZZA, C. DIMIGEN, H. EHRENREICH, and M. HECKER Stretch-induced endothelin B receptor-mediated apoptosis in vascular smooth muscle cells FASEB J, May 1, 2000; 14(7): 991 - 998. [Abstract] [Full Text] |
||||
![]() |
H. J. Oskarsson, L. Coppey, R. M. Weiss, and W.-G. Li Antioxidants attenuate myocyte apoptosis in the remote non-infarcted myocardium following large myocardial infarction Cardiovasc Res, February 1, 2000; 45(3): 679 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Dispersyn, M. Borgers, and W. Flameng Apoptosis in chronic hibernating myocardium: sleeping to death? Cardiovasc Res, February 1, 2000; 45(3): 696 - 703. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |